- Home
- ALCO vs AVTX Comparison
ALCO vs AVTX Comparison
Compare ALCO & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALCO | AVTX |
|---|---|---|
| Founded | 1960 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.7M | 339.9M |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ALCO | AVTX |
|---|---|---|
| Price | $37.90 | $13.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $32.57 |
| AVG Volume (30 Days) | 25.3K | ★ 585.6K |
| Earning Date | 02-04-2026 | 03-26-2026 |
| Dividend Yield | ★ 0.53% | N/A |
| EPS Growth | N/A | ★ 81.66 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,813,137.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 2312.27 |
| 52 Week Low | $27.61 | $3.39 |
| 52 Week High | $43.20 | $20.72 |
Technical Indicators
Market Signals| Indicator | ALCO | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 35.98 | 32.45 |
| Support Level | $37.14 | $8.87 |
| Resistance Level | $38.40 | $16.40 |
| Average True Range (ATR) | 1.41 | 1.12 |
| MACD | -0.25 | -0.45 |
| Stochastic Oscillator | 11.51 | 1.10 |
Price Performance
Historical ComparisonAbout ALCO Alico Inc.
Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).